Impact of the HIV-1 protease N88S substitution on protease inhibitor susceptibility and clinical response
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1758-2652
- Extent
-
Online-Ressource
- Language
-
Englisch
- Notes
-
online resource.
- Bibliographic citation
-
Impact of the HIV-1 protease N88S substitution on protease inhibitor susceptibility and clinical response ; volume:11 ; number:1 ; day:10 ; month:11 ; year:2008 ; pages:1 ; date:12.2008
Journal of the International AIDS Society / International AIDS Society ; 11, Heft 1 (10.11.2008), 1, 12.2008
- Creator
-
Uy, J.
- Contributor
-
Lataillade, M.
Thiry, A.
McGrath, D.
Seekins, D.
Hanna, G.
SpringerLink (Online service)
- DOI
-
10.1186/1758-2652-11-S1-P185
- URN
-
urn:nbn:de:1111-2016052053769
- Rights
-
Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
14.08.2025, 11:03 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Uy, J.
- Lataillade, M.
- Thiry, A.
- McGrath, D.
- Seekins, D.
- Hanna, G.
- SpringerLink (Online service)
Other Objects (12)
Proteochemometric modeling of HIV protease susceptibility
Outcome of protease inhibitor substitution with nevirapine in HIV-1 infected children
Cell-based Assay for Testing Susceptibility of HIV-1 to Protease Inhibitors
Non-active site mutants of HIV-1 protease influence resistance and sensitisation towards protease inhibitors
Synthesis of the First FDA-Approved HIV Protease Inhibitor
Alteration of HIV epitope processing and presentation by HIV protease inhibitors
Analysis of the efficacy of HIV protease inhibitors against SARS-CoV-2′s main protease
HIV-1 protease-induced apoptosis
Asymmetrische Synthese potentieller HIV-Protease-Inhibitoren auf zyklischer Harnstoff-Basis
Neue HIV-1-Protease-Inhibitoren : Synthese, Charakterisierung und biologische Aktivität
Strukturbasiertes Design, Synthese und Affinitätsbestimmung neuartiger HIV-1-Protease-Inhibitoren
3-funktionalisierte Tetronsäuren und Synthese von HIV-I-Protease-Inhibitoren
Proteochemometric modeling of HIV protease susceptibility
Outcome of protease inhibitor substitution with nevirapine in HIV-1 infected children
Cell-based Assay for Testing Susceptibility of HIV-1 to Protease Inhibitors
Non-active site mutants of HIV-1 protease influence resistance and sensitisation towards protease inhibitors
Synthesis of the First FDA-Approved HIV Protease Inhibitor
Alteration of HIV epitope processing and presentation by HIV protease inhibitors
Analysis of the efficacy of HIV protease inhibitors against SARS-CoV-2′s main protease
HIV-1 protease-induced apoptosis
Asymmetrische Synthese potentieller HIV-Protease-Inhibitoren auf zyklischer Harnstoff-Basis
Neue HIV-1-Protease-Inhibitoren : Synthese, Charakterisierung und biologische Aktivität
Strukturbasiertes Design, Synthese und Affinitätsbestimmung neuartiger HIV-1-Protease-Inhibitoren
3-funktionalisierte Tetronsäuren und Synthese von HIV-I-Protease-Inhibitoren
Proteochemometric modeling of HIV protease susceptibility
Outcome of protease inhibitor substitution with nevirapine in HIV-1 infected children
Cell-based Assay for Testing Susceptibility of HIV-1 to Protease Inhibitors
Non-active site mutants of HIV-1 protease influence resistance and sensitisation towards protease inhibitors
Synthesis of the First FDA-Approved HIV Protease Inhibitor
Alteration of HIV epitope processing and presentation by HIV protease inhibitors
Analysis of the efficacy of HIV protease inhibitors against SARS-CoV-2′s main protease
HIV-1 protease-induced apoptosis
Asymmetrische Synthese potentieller HIV-Protease-Inhibitoren auf zyklischer Harnstoff-Basis
Neue HIV-1-Protease-Inhibitoren : Synthese, Charakterisierung und biologische Aktivität
Strukturbasiertes Design, Synthese und Affinitätsbestimmung neuartiger HIV-1-Protease-Inhibitoren